Pini Ben-Elazar - 18 Mar 2026 Form 3 Insider Report for REGENTIS BIOMATERIALS LTD. (RGNT)

Role
Director
Signature
/s/ Pini Ben-Elazar
Issuer symbol
RGNT
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:30:04 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ben-Elazar Pini Director C/O REGENTIS BIOMATERIALS LTD., 60 MEDINAT HAYEHUDIM, HERZLIYA, ISRAEL /s/ Pini Ben-Elazar 18 Mar 2026 0002114839

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RGNT Ordinary Shares, no par value per share 128,666 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RGNT Employee Stock Option (Right to Buy) 18 Mar 2026 Common Stock 39,295 $0.0100 Direct F1
holding RGNT Warrants to purchase ordinary shares 18 Mar 2026 Common Stock 15,831 $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option grant is fully vested as of this date.
F2 The warrants are currently exercisable and have a three year term.